Abselion
PrivateLast Round
Series A
Dec 4, 2024
Total Funding Raised
$11.05M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Abselion operates in Frontier & Industrial Tech and is based in Cambridge. Its latest recorded funding round was a Series A round in December 2024.
Abselion is a life sciences tools company that develops and manufactures automated analytical instruments for protein quantification.
Sector
Frontier & Industrial Tech
Verticals
Biotech Equipment, Sensors, Smart Manufacturing, Data Visualization
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abselion Comparables
Compare Abselion with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Refeyn | 79% | |
| Mesa Laboratories Inc | 74% | |
| Thermo Fisher Scientific Inc. | 73% |
For institutional investors. Book with your work email.
Abselion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 4, 2024 | ||||
| Seed | Apr 20, 2021 | ||||
| Grant | Sep 11, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Abselion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NG Bio | Seed |
| Swiss Health Angels | Seed |
| The Untitled ventures | Series A |
| BGF | Series A |
| M Ventures | Series A |
| Cambridge Enterprise | Seed |
| R42 Group | Series A, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 92% MoM.
- Jul 28, 2026
Monthly visitors grew 354% MoM, from 323 to 1.5K.
For institutional investors. Book with your work email.
Abselion Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Abselion's valuation, stock price, and market status.
Is Abselion a public or private company?
Abselion is a private company.
What is the current stock price of Abselion?
Abselion is a private company, so its shares have no public market price. Caplight tracks Abselion's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abselion worth (valuation)?
Valuation information for Abselion is not publicly available.
Can I buy Abselion stock?
Abselion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abselion's last funding round?
Abselion's most recent funding round was Series A on December 4, 2024.
Who are the main investors in Abselion?
Key investors in Abselion include M Ventures, Cambridge Enterprise.
Will Abselion IPO soon?
No public IPO plans have been announced for Abselion.
How can I track Abselion secondary market activity?
Caplight tracks bids, offers, and trades in Abselion's shares on secondary markets.